Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical ...

Montgomery County's Globus Medical has agreed to acquire a California life sciences company focused on treating chronic pain ...

In a report released today, David Saxon from Needham maintained a Hold rating on Globus Medical (GMED – Research Report). The company’s shares ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Globus Medical (GMED) has agreed to buy Nevro (NVRO) through an all-cash deal valued at around $250M. Read more here.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Globus Medical (GMED – Research Report) and ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, GMED should be on investors' short list. Before you invest in Globus Medical, Inc. (GMED), want to know the best stocks to buy for ...

KBC Group NV grew its position in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities ...

Shares of NYSE GMED opened at $87.09 on Thursday. Globus Medical has a 12 month low of $49.33 and a 12 month high of $90.48. The firm has a market capitalization of $11.86 billion, a PE ratio of ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.